Cite

HARVARD Citation

    Huang, M. et al. (2013). MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib. Molecular oncology. 7 (1), pp. 112-120. [Online]. 
  
Back to record